You are here

Aerobika* Oscillating Positive Expiratory Pressure Therapy System

Get your breath back

The Aerobika* Oscillating PEP (OPEP) device is drug-free, easy-to-use and clinically supported1. Patient feedback indicates that using the device daily improves the ease in bringing up mucus, decreases cough frequency, reduces breathlessness, increases exercise tolerance and improves quality of life2. Exhaling into the device will assist in loosening and helping remove the mucus from your lungs.

Excess mucus in your lungs may lead to health problems.

Excess mucus in your lungs can cause shortness of breath, difficulty completing simple chores, and poor quality of life. If not addressed, excess mucus can lead to lung infections and make your condition worse3-5.

Current drug treatments have been unable to show a significant impact on removing mucus6-16.

Aerobika device

Want to learn more? See our Aerobika* OPEP Device Frequently Asked Questions.

How the Aerobika* OPEP Device Works

Airway with a mucus plug

Resistance holds the airway open

Pulses help thin and loosen mucus while the airways are held open

Did You Know?
  • number three
    COPD is the 3rd leading cause of death, right behind heart disease and stroke17.
  • Man out of breath.
    Shortness of breath is not a normal part of aging.
  • Emergency department.
    Excess mucus in the lungs can lead to recurring lung infections and a greater chance of being hospitalized1.
  • down arrow
    Excess mucus plays a significant role in COPD progression.
How to Use
Instructions step 1

Step 1

CLOSE LIPS around mouthpiece then INHALE and HOLD 2-3 seconds.

Instructions step 2

Step 2

EXHALE - slowly, steady, firmly

Instructions step 3

Step 3

REPEAT and cough as directed.

User Guide


Use Active Exhalation

Active exhalation can best be described as the type of effort required to start blowing up a balloon - but is not as forceful as blowing out candles. Keep your cheeks flat as you exhale.

Try a 'Huff Cough'

A 'huff cough' will help move mucus up and out of your lungs. Just like when you use your breath to create fog on a mirror, you would take a short, shallow breath and exhale forcefully with your mouth in an 'O' shape. Contact your healthcare professional if you need help with the proper technique.

MDEA 2014 Gold Winner

Further evidence supports that the Aerobika* OPEP device is an important treatment for those suffering from COPD. Learn More...

The Aerobika* OPEP device earned Gold at the 2014 Medical Design Excellence Awards (MDEA)! Learn More...

Learn more about the Medical Design Excellence Awards. Learn More...

  • "I have had chronic cough for 5 years now. After just 2 uses, I slept through the night without coughing several times during the night. I normally had severe long cough spells at least once a week, coughing until I threw up, sometimes lasting half hour."

  • “There’s funny little ways that it’s made a difference. I was coughing so hard and there was so much pressure in my lungs that I had to sleep sitting up. It was hard to go out walking my dog for example because I was so breathless. So I really find the device helps to clear my lungs, I’ve been able to lie down at night, so that just in itself is a very good thing because it’s better rest.”

  • ”Brilliant”

  • “The Aerobika* OPEP device has proven to be more easy [sic] to use and monitor. We struggled to get my daughter to perform her chest therapy using the traditional [competitive] device. This has proven to be more effective.”

  • “It means better health, it means I feel better. It also helps to just clear my airways in everyday situations if I want to go out to a show which can be hard to do when you’re a cougher. I use this a lot before I go to clear my airways so I don’t have to run into that problem when I’m out.”

Where to Buy

Please call or visit your local pharmacist to inquire about product availability (click here for a full list), or contact us for more information.

1 S Svenningsen et al. Presented at ERS 2014.
2 Patient satisfaction survey demonstrated consistent results o the patient reported outcomes in the clinical study, n=506.

3Tesfaigzi Y et al. Clinical and Applied Immunology Reviews 2006;6(1):21-36.
4 Burgel PR, Martin C. European Respiratory Review 2010;19(116):94-96.
5 Prescott E et al. European Respiratory Journal 1995;8(8):1333-1338.
6 Perry, RJ, Smaldone GC. Journal of Aerosol Medicine 1990;3(3):187-196.
7 Hogg JC et al. American Journal of Respiratory and Critical Care Medicine 2007;176(5):454.
8 Burgel PR et al. European Respiratory Journal 2004;24(4):594-600.
9 Ramos FL et al. International Journal of COPD 2014;9:139-150.
10 Pavia D et al. European journal of respiratory diseases 1983;128(Suppl):304.
11 Hasani A et al. CHEST 2004;125(5):1726-1734.
12 Baraniuk JN, Zheng Y.Clinical & Experimental Allergy Reviews 2010;10(1):12-19.
13 Rogers D, Barnes PJ. Annals of medicine 2006;38(2):116-125.
14 Salathe M et al. CHEST 1996; 110(4):1048-1057.
15 Poole PJ. International Journal of Chronic Obstructive Pulmonary Disease 2006;1(2):123
16 Rogers DF. Pulmonary Pharmacology & Therapeutics 2005;18(1):1-8.
17 World Health Organization, Fact sheet N°310 Updated May 2014